Health

GC Pharma COVID-19 mRNA Vaccine: Phase 1 Trial Approved

by Archynetys Health Desk

GC Green Cross (CEO Eun-cheol Heo) corona19 The domestic phase 1 clinical trial protocol (IND) for the mRNA vaccine candidate ‘GC4006A’ has been approved by the Ministry of Food and Drug Safety…

The Archynetys Health Desk covers public health, medical research, healthcare systems, wellness trends, and science-backed developments that affect readers globally. This desk applies added care to sourcing, evidence, nuance, and plain-language explanation, especially on high-impact health topics.

Related Posts

Measles Outbreak Sparks Alarm in California as Cases...

14-Protein Blood Signature Predicts Lung Cancer Risk 5...

Children who sleep poorly ‘turn into depressed teenagers

High Triglycerides Over 200 mg/dL Pose Heart Risks

Chronic Kidney Disease to Become 5th Leading Cause...

Infections are major ‘health hazard’ for people with...

Ahn Sun-young reveals protein-first meal strategy for 11kg...

Selenium Levels Linked to Higher Mortality Risk in...

DEET’s Food Association Attracts Mosquitoes

Pneumonia Vaccine: Recommended for Adults 50+ and Kids...

Leave a Comment